This Government Contract opportunity from Department Of Veterans Affairs was posted on June 29, 2012. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

65--Histology Supplies - PVAHCS

Awarded

VA25812Q0064Federal

Submission Closed05/22/2012, 12:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

Federal

Blood Type IVD Reagents and Sera Supply

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

6550--Blood Type IVD Reagents

Solicitation # 36C26227Q0043

The Department of Veterans Affairs, through the Network Contract Office 22, is seeking quotations for solicitation 36C26227Q0043 to establish a Blanket Purchase Agreement for blood type IVD reagents, supplies, and consumables for manual testing at VISN 22 facilities. The contract is structured with a 12-month base ordering period and four subsequent 12-month option periods, for a total potential duration of five years. This is a commercial products and services acquisition under FAR Part 12, with an emphasis on FDA regulatory compliance, potency requirements, and strict cold-chain and temperature-monitoring controls during shipment. All items must be quoted as F.O.B. destination and delivered Monday through Friday between 8am and 4pm. Award will be based on the best value to the government, evaluated through a comparative assessment of technical understanding, price, and quality, regulatory compliance, and product traceability. Technical evaluation considers the offeror's ability to provide a full antigen profile and their procedures for handling nonconforming or defective products. Pricing will be evaluated based on the total cost for the base period and all option periods, including a six-month price addition for the final performance period per FAR 52.217-8. Quotations must be submitted via email to the contract specialist by November 16, 2026, and must include a completed five-year pricing spreadsheet, a past performance questionnaire, and required certifications regarding telecommunications and trade agreements.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-27-T-1071

Solicitation SPE2DS-27-T-1071, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. Each case contains 12 kits with 2 tests per kit. The items must be stored between 2-30 degrees Celsius and have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of the order, with a final delivery date of October 30, 2026, to the USS IDAHO (SSN 799). The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires labels to include the contract or lot number and the date of manufacture, expiration, or retest. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area Workflow system for electronic invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, the Buy American Act, and the prohibition of covered defense telecommunications equipment. Quotations are due by November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CULTURE MEDIUM, THAYER-

Solicitation # SPE2DS-27-T-1066

Solicitation SPE2DS-27-T-1066 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of Thayer-Martin Modified (MTM II) Agar culture medium, identified by NSN 6550-01-711-1542. This dark brown, ready-to-use plated medium is specifically designed for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. The product is delivered in packages of 100 plates and requires strict refrigeration storage between 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) and must not be frozen. The contract mandates a non-extendable shelf life of three months, with a requirement that no more than 14 days elapse between the date of manufacture and the date of delivery to the government. Delivery is set for JBER, Alaska, with a required delivery date of October 27, 2026, under FOB Destination terms. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1 and shelf-life labels following MMS1C. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and safeguarding of covered defense information. Evaluation will consider technical data for any alternate products offered and may include HUBZone price evaluation preferences. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of ALBAcyte Blood Bank ReagentsThis subcontract involves the manufacture and supply of specialized ALBAcyte blood bank reagents for prime contractors supporting the Department of Veterans Affairs North Texas Health Care System. The scope of work includes the delivery of A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated RBCs. To ensure product efficacy, the contractor must utilize shipping containers that maintain reagent integrity and adhere to a defined Quality Plan and FDA approval standards. Deliveries are to be made FOB Destination to the Transfusion Medicine Unit located in Dallas, Texas. The contract is categorized under NAICS code 325413 and is managed through the Department of Veterans Affairs Network Contract Office 17.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6550--Blood Bank Reagents

Solicitation # 36C25727Q0065

The Department of Veterans Affairs VA North Texas Health Care System is issuing a Sources Sought Notice to identify qualified vendors capable of providing blood bank reagents for the Transfusion Medicine Unit in Dallas, Texas. These reagents, including ALBAcyte A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated Red Blood Cells, are essential for manual blood typing and serum antibody detection used in cross-matching blood for transfusions. The anticipated acquisition strategy includes a base year starting May 1, 2027, with four subsequent one-year option periods extending through April 30, 2032. To be considered, vendors must be FDA approved, provide documentation of such approval, and maintain a defined quality plan with adequate supply availability. All shipments must be FOB Destination, and the contractor is responsible for providing appropriate shipping containers. Interested vendors must submit an electronic capability statement in PDF or Word format, including the place of manufacture for all listed reagents, to the designated contract specialist by November 5, 2026, at 9:00 AM CST. This notice is for market research purposes only to determine the appropriate acquisition strategy, such as a small business set-aside, and does not constitute a formal solicitation.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6505--DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)

Solicitation # 36C77027Q0015

The Department of Veterans Affairs, National CMOP Office, is conducting market research through a Sources Sought announcement to identify qualified sources for the procurement of Drawtex Dressing, 4in X 4in, packaged as 10ct per box. This action is for market research purposes only and is not a formal solicitation for quotes; therefore, no contract will be awarded based on this specific announcement. The place of performance is located in Ladson, South Carolina, and the primary point of contact is Contract Specialist Claudine Challinor. Interested respondents must submit their information via email by November 3, 2026. Required details include the company's SAM Unique ID Number, business size (Small, Large, SDVOSB, or VOSB), and point of contact information. Specifically, the government is seeking to determine if the respondent is the manufacturer, the manufacturer's product number, and the place of manufacturing. If the respondent is not the manufacturer, they must provide a letter of authorization from the original equipment manufacturer or provide detailed product literature and specifications for alternative products that demonstrate similarities to the Drawtex hydro conductive wound dressing.

National Cmop Office (36C770)

POSTED

DEADLINE

6550--Optilite analyzer reagents

Solicitation # 36C26227Q0052

The Department of Veterans Affairs, Southern Arizona Healthcare System, is soliciting a Firm-Fixed Price Blanket Purchase Agreement under solicitation 36C26227Q0052 for the procurement of FDA-approved reference testing reagents and consumables validated for use on the Optilite analyzer. The scope includes specific items such as Freelite Kappa, Freelite Lambda, and Ceruloplasmin reagents, as well as TENCELL cuvettes and sample cups. To ensure system performance and safety, all materials must be manufactured by Binding Site Laboratories, and substitutions are prohibited. The contract is issued as a full and open competition under NAICS code 325413, with a total estimated period of performance of sixty months, consisting of a base period from November 9, 2026, to November 8, 2027, followed by four one-year option periods. The award will be granted to the responsible offeror whose proposal is most advantageous to the government, based on a technical acceptability review of the Statement of Work and the lowest price. Deliveries are required to be made to various VA Medical Centers across Arizona, California, and New Mexico, with standard orders delivered within four working days of placement. All shipments must be destination-based, with the vendor assuming all shipping costs and adhering to strict packaging standards to prevent damage. Invoicing is handled electronically through the Department of Veterans Affairs Financial Services Center in accordance with the Prompt Payment Act. Quotes must be submitted via email to Contract Specialist Carlos Magana by November 4, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Supply of i-STAT PT Plus Control Reagent Level 1This subcontract involves the procurement and delivery of i-STAT PT Plus Control Reagent Level 1 for coagulation testing to support prime contractors fulfilling Department of Defense supply contracts. The scope of work requires the delivery of two boxes, each containing ten 1.0 mL units, shipped FOB Destination to a performance location in APO 96260-5479. To ensure quality and safety, all supplied reagents must adhere to Regulation 864.7750 Class II requirements and maintain full compliance with Registration, Listing, Labeling, and Good Manufacturing Practices. This requirement is managed under NAICS code 325413 for the Medical Supply Chain MD Surg FSF agency.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL SET, BLOOD CHEM

Solicitation # SPE2DS-27-T-0906

Solicitation SPE2DS-27-T-0906 is a request for quotations from DLA Troop Support for two sets of DXH 500 Series Blood Chemistry Control (NSN 6550-01-688-9090). This assayed whole blood control is used to monitor multi-parameter hematology cell counters and includes abnormal low, normal, and abnormal high components. The items must be stored refrigerated and upright between 2 to 8 degrees Celsius and protected from freezing and overheating. Delivery is required within 20 days after receipt of order, with a required delivery date of October 27, 2026, under FOB Destination terms. The contract imposes strict shelf-life requirements, specifying a non-extendable shelf life of 3 months, with no more than 13 days elapsed from the date of manufacture to the date of delivery. Packaging must be commercial and compliant with RP001 and MIL-STD-2073-1E, while marking must adhere to Medical Marking Standard No. 1. Invoicing is to be processed electronically via the Wide Area Workflow system. This is not a small business set-aside, and the procurement falls under NAICS code 325413. Compliance with the Buy American and Balance of Payments Program and DFARS safeguarding of covered defense information is required.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-27-T-0950

Solicitation SPE2DS-27-T-0950 is a Request for Quotations issued by the Department of Defense, DLA Troop Support Medical Supply Chain, for the procurement of two boxes of i-STAT PT Plus Control Reagent Level 1 (NSN 6550-01-728-5703). This reagent is used for coagulation testing and is compatible with the i-STAT PT Plus cartridge and the i-STAT 1 Government Field Kit analyzer. Each box contains ten 1.0 mL units. The required delivery date is October 23, 2026, with a delivery window of 83 days after award. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contract mandates strict quality and storage requirements, including refrigeration between 2 to 8 degrees Celsius and a non-extendable shelf life of 12 months. Items must be delivered within one month of the manufacture date. Packaging must be commercial and adhere to MIL-STD-2073-1E and RP001, with marking compliant with Medical Marking Standard No. 1. Labels must include the contract/lot number and manufacture or expiration dates. The procurement is not a small business set-aside, though a HUBZone price evaluation preference may be applied. Compliance with the Buy American Act and DFARS domestic material restrictions is required, and electronic invoicing must be processed through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems

Solicitation # HT942627QE003

The Defense Health Agency is soliciting quotations to establish a Blanket Purchase Agreement (BPA) for the recurring resupply of consumable products for three Terumo Trima Accel Blood Collection Systems used by the USAISR Combat Casualty Care Research Team 1 in Texas. To maintain FDA approval and satisfy research protocols, the contractor must provide original manufacturer-supplied consumables, including Teruflex 500ml collection bags, Trima Platelet Kits, Isoplate Solution (PAS-F), TSCD Wafers, ACD-A Solution, and 150 mL couplers. This procurement is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses under NAICS 325413. The resulting BPA will have a 60-month ordering period with a total ceiling of 35 million dollars, though some documentation notes a lower limit of 350,000 dollars. Individual call orders are capped at 50,000 dollars, while Government Purchase Card orders are limited to 15,000 dollars. Awards will be made on a Lowest Price Technically Acceptable basis, with technical capability rated as pass or fail. All payment requests and receiving reports must be processed electronically through the Wide Area WorkFlow system. Quotations are due by November 6, 2026, and must be submitted in two separate volumes covering technical capability and pricing.

Army Medical Resources Acq Activity

POSTED

7 days ago

DEADLINE

in 7 days

AI Contract Overview

This award notice pertains to solicitation VA25812Q0064 for the procurement of histology supplies to support the Department of Veterans Affairs, specifically through the Network Contract Office 22G. The contract is categorized under NAICS code 325413, which relates to the manufacturing of other medical and surgical instruments and apparatus. The procurement process was managed by an office located in Mesa, Arizona. While the notice identifies the agency as the Department of Veterans Affairs, specific details regarding the set-aside status and the final place of performance were not provided in the available data.

General Info

VA procurement of histology supplies via solicitation VA25812Q0064 for Network Contract Office 22G.

Agency

Department Of Veterans Affairs → 258-NETWORK Cntrct Office 22G (36C258)

Contract Value

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

AZ, USA

Set-Aside

NONE

Awardee

VENTANA MEDICAL SYSTEMS, INC

Award Issued Date

05/21/2012, 12:00:00 AM UTC

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded

PostedDec 9

Combined Synopsis

AwardedMay 21

Contract was awarded

Submission Closed

05/22/2012, 12:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → 258-NETWORK Cntrct Office 22G (36C258)

ContactsNo contacts available

OfficeMESA, AZ, 85212, USA

Organization / AgencyDepartment Of Veterans Affairs → 258-NETWORK Cntrct Office 22G (36C258)

Office AddressMESA, AZ, 85212, USA

ContactsNo contact information available

Full Description

CONBINED SYNOPSIS/SOLICATION FOR COMMERCIAL SUPPLIES This is a combined synopsis/solicitation for commercial supplies prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 Streamlined Procedures for Evaluation and Solicitation for Commercial Items and 13.5 Test Program for Certain Commercial items as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. The solicitation is being issued as Request for Quote No. VA25-12-Q-0064. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-54. The North American Industrial Classification System (NAICS) code for the required supplies is 325413, with a business size standard of 500 employees. This combined synopsis/solicitation is unrestricted and all quotes received by 12:00 PM local time on December 23, 2011 will be considered by the Government. *The Phoenix VA Health Care System requires the following BRAND NAME or EQUAL Items: CLIN 0000 Base Period - Date of Award through September 30, 2012 CLIN Name Stock Number Unit Min Qty Est Qty Max Qty Unit Price Total Price 0001 Label, Blank, Flap, 500 Roll 1358501 EA 1 5 10 0002 Liquid Coverslip (High Tempature) - 2 ltr Bottle 650-010 EA 7 23 42 0003 Endogenous Biotin Blocking Kit, CE (250 tests per kit) 760-050 EA 0 1 11 0004 Amplification Kit, CE (100 tests per kit) 760-080 EA 1 4 14 0005 iView DAB Detection Kit (250 tests per kit) 760-091 EA 1 3 14 0006 Negative Control Mouse IG (250 tests per kit) 760-2014 EA 1 2 11 0007 PROTEASE 1 (250 test per kit) 760-2018 EA 0 1 11 0008 HEMATOXYLIN (250 test per kit) 760-2021 EA 0 1 11 0009 BLUING REAGENT (250 tests per kit) 760-2037 EA 4 8 21 0010 CONFIRM ANTI-PSA (polyclonal) Primary Antigen (50 test per kit) 760-2506 EA 0 1 11 0011 Anti-CHROMOGRANIN A (LK2H10) PAB (50 test per kit) 760-2519 EA 1 3 14 0012 CONFIRM anti-CD20 (L26) PAB (50 tests per kit) 760-2531 EA 0 1 11 0013 Anti-Keratin, Pan (AE1/AE3 & PCK26) PAB (50 tests per kit) 760-2595 EA 1 2 11 0014 Cell Marque, Cytokeratin 5&6 (D5&16B4) (50 tests per kit) 790-4554 EA 1 2 11 0015 Cell Marque, CD45 (2B11 & PD7/26) (50 tests per kit) 760-4279 EA 0 1 11 0016 CDX-2 (CDX2-88) PAb, Cell Marque (50 tests per kit) 760-4380 EA 0 1 11 0017 Napsin A (Polyclonal) (50 test per kit) 760-4446 EA 0 1 11 0018 ultraView Universal Alkaline Phosphatase Red Detection (250 tests per kit) 760-501 EA 1 2 11 0019 Hematoxylin II (250 tests per kit) 790-2208 EA 3 7 15 0020 CONFIRM S100 (4C4.9) (50 tests per kit) 790-2914 EA 1 4 14 0021 CONFIRM Vimentin (V9) (50 tests per kit) 790-2917 EA 0 1 11 0022 CONFIRM CD34 (QBEnd/10) (50 tests per kit) 790-2927 EA 0 1 11 0023 CONFIRM MART-1/melan A (A103) (50 tests per kit) 790-2990 EA 1 4 14 0024 CONFIRM anti-CD3 (2GV6) (50 tests per kit) 790-4341 EA 1 2 11 0025 CONFIRMMelanosome (HMB45) Mouse (50 tests per kit) 790-4366 EA 1 2 11 0026 CONFIRM Thyroid Transcription Factor-1 (TTF-1) (8G7G3/1) (50 tests per kit) 790-4398 EA 1 3 14 0027 CONFIRM Synaptophysin (SP11) Rabbit (50 tests per kit) 790-4407 EA 1 2 11 0028 CONFIRM Cytokeratin 20 (SP33) Rabbit (50 tests per kit) 790-4431 EA 1 3 14 0029 CONFIRM Cytokeratin 7 (SP52) Rabbit (50 tests per kit) 790-4462 EA 1 3 14 0030 Confirm CD56 (123C3) Mouse (50 tests per kit) 790-4465 EA 1 1 11 0031 P63 (4A4) Mouse (50 tests per kit) 790-4509 EA 1 3 14 0032 EZ Prep (10x) (2 L bottle) 950-102 EA 2 5 17 0033 SSC (10X) (2 L bottle) 950-110 EA 1 3 14 0034 Cell Conditioning 1 (CC1) (2 L bottle) 950-124 EA 1 2 14 0035 Reaction Buffer (10X) (2 L bottle) 950-300 EA 7 12 28 Base Period Estimated Total $ *VENDOR SHOULD USE EST. QTY WHEN PROVIDNG TOTAL PRICE CLIN 0001 Option Year One (1) - October 1, 2012 through September 30, 2013 CLIN Name Stock Number Unit Min Qty Est Qty Max Qty Unit Price Total Price 1001 Label, Blank, Flap, 500 Roll 1358501 EA 1 5 10 1002 Liquid Coverslip (High Tempature) - 2 ltr Bottle 650-010 EA 7 23 42 1003 Endogenous Biotin Blocking Kit, CE (250 tests per kit) 760-050 EA 0 1 11 1004 Amplification Kit, CE (100 tests per kit) 760-080 EA 1 4 14 1005 iView DAB Detection Kit (250 tests per kit) 760-091 EA 1 3 14 1006 Negative Control Mouse IG (250 tests per kit) 760-2014 EA 1 2 11 1007 PROTEASE 1 (250 test per kit) 760-2018 EA 0 1 11 1008 HEMATOXYLIN (250 test per kit) 760-2021 EA 0 1 11 1009 BLUING REAGENT (250 tests per kit) 760-2037 EA 4 8 21 1010 CONFIRM ANTI-PSA (polyclonal) Primary Antigen (50 test per kit) 760-2506 EA 0 1 11 1011 Anti-CHROMOGRANIN A (LK2H10) PAB (50 test per kit) 760-2519 EA 1 3 14 1012 CONFIRM anti-CD20 (L26) PAB (50 tests per kit) 760-2531 EA 0 1 11 1013 Anti-Keratin, Pan (AE1/AE3 & PCK26) PAB (50 tests per kit) 760-2595 EA 1 2 11 1014 Cell Marque, Cytokeratin 5&6 (D5&16B4) (50 tests per kit) 790-4554 EA 1 2 11 1015 Cell Marque, CD45 (2B11 & PD7/26) (50 tests per kit) 760-4279 EA 0 1 11 1016 CDX-2 (CDX2-88) PAb, Cell Marque (50 tests per kit) 760-4380 EA 0 1 11 1017 Napsin A (Polyclonal) (50 test per kit) 760-4446 EA 0 1 11 1018 ultraView Universal Alkaline Phosphatase Red Detection (250 tests per kit) 760-501 EA 1 2 11 1019 Hematoxylin II (250 tests per kit) 790-2208 EA 3 7 15 1020 CONFIRM S100 (4C4.9) (50 tests per kit) 790-2914 EA 1 4 14 1021 CONFIRM Vimentin (V9) (50 tests per kit) 790-2917 EA 0 1 11 1022 CONFIRM CD34 (QBEnd/10) (50 tests per kit) 790-2927 EA 0 1 11 1023 CONFIRM MART-1/melan A (A103) (50 tests per kit) 790-2990 EA 1 4 14 1024 CONFIRM anti-CD3 (2GV6) (50 tests per kit) 790-4341 EA 1 2 11 1025 CONFIRMMelanosome (HMB45) Mouse (50 tests per kit) 790-4366 EA 1 2 11 1026 CONFIRM Thyroid Transcription Factor-1 (TTF-1) (8G7G3/1) (50 tests per kit) 790-4398 EA 1 3 14 1027 CONFIRM Synaptophysin (SP11) Rabbit (50 tests per kit) 790-4407 EA 1 2 11 1028 CONFIRM Cytokeratin 20 (SP33) Rabbit (50 tests per kit) 790-4431 EA 1 3 14 1029 CONFIRM Cytokeratin 7 (SP52) Rabbit (50 tests per kit) 790-4462 EA 1 3 14 1030 Confirm CD56 (123C3) Mouse (50 tests per kit) 790-4465 EA 1 1 11 1031 P63 (4A4) Mouse (50 tests per kit) 790-4509 EA 1 3 14 1032 EZ Prep (10x) (2 L bottle) 950-102 EA 2 5 17 1033 SSC (10X) (2 L bottle) 950-110 EA 1 3 14 1034 Cell Conditioning 1 (CC1) (2 L bottle) 950-124 EA 1 2 14 1035 Reaction Buffer (10X) (2 L bottle) 950-300 EA 7 12 28 Option Year One (1) Estimated Total $ *VENDOR SHOULD USE EST. QTY WHEN PROVIDNG TOTAL PRICE CLIN 2000 Option Year Two (2) - October 1, 2013 through September 30, 2014 CLIN Name Stock Number Unit Min Qty Est Qty Max Qty Unit Price Total Price 2001 Label, Blank, Flap, 500 Roll 1358501 EA 1 5 10 2002 Liquid Coverslip (High Tempature) - 2 ltr Bottle 650-010 EA 7 23 42 2003 Endogenous Biotin Blocking Kit, CE (250 tests per kit) 760-050 EA 0 1 11 2004 Amplification Kit, CE (100 tests per kit) 760-080 EA 1 4 14 2005 iView DAB Detection Kit (250 tests per kit) 760-091 EA 1 3 14 2006 Negative Control Mouse IG (250 tests per kit) 760-2014 EA 1 2 11 2007 PROTEASE 1 (250 test per kit) 760-2018 EA 0 1 11 2008 HEMATOXYLIN (250 test per kit) 760-2021 EA 0 1 11 2009 BLUING REAGENT (250 tests per kit) 760-2037 EA 4 8 21 2010 CONFIRM ANTI-PSA (polyclonal) Primary Antigen (50 test per kit) 760-2506 EA 0 1 11 2011 Anti-CHROMOGRANIN A (LK2H10) PAB (50 test per kit) 760-2519 EA 1 3 14 2012 CONFIRM anti-CD20 (L26) PAB (50 tests per kit) 760-2531 EA 0 1 11 2013 Anti-Keratin, Pan (AE1/AE3 & PCK26) PAB (50 tests per kit) 760-2595 EA 1 2 11 2014 Cell Marque, Cytokeratin 5&6 (D5&16B4) (50 tests per kit) 790-4554 EA 1 2 11 2015 Cell Marque, CD45 (2B11 & PD7/26) (50 tests per kit) 760-4279 EA 0 1 11 2016 CDX-2 (CDX2-88) PAb, Cell Marque (50 tests per kit) 760-4380 EA 0 1 11 2017 Napsin A (Polyclonal) (50 test per kit) 760-4446 EA 0 1 11 2018 ultraView Universal Alkaline Phosphatase Red Detection (250 tests per kit) 760-501 EA 1 2 11 2019 Hematoxylin II (250 tests per kit) 790-2208 EA 3 7 15 2020 CONFIRM S100 (4C4.9) (50 tests per kit) 790-2914 EA 1 4 14 2021 CONFIRM Vimentin (V9) (50 tests per kit) 790-2917 EA 0 1 11 2022 CONFIRM CD34 (QBEnd/10) (50 tests per kit) 790-2927 EA 0 1 11 2023 CONFIRM MART-1/melan A (A103) (50 tests per kit) 790-2990 EA 1 4 14 2024 CONFIRM anti-CD3 (2GV6) (50 tests per kit) 790-4341 EA 1 2 11 2025 CONFIRMMelanosome (HMB45) Mouse (50 tests per kit) 790-4366 EA 1 2 11 2026 CONFIRM Thyroid Transcription Factor-1 (TTF-1) (8G7G3/1) (50 tests per kit) 790-4398 EA 1 3 14 2027 CONFIRM Synaptophysin (SP11) Rabbit (50 tests per kit) 790-4407 EA 1 2 11 2028 CONFIRM Cytokeratin 20 (SP33) Rabbit (50 tests per kit) 790-4431 EA 1 3 14 2029 CONFIRM Cytokeratin 7 (SP52) Rabbit (50 tests per kit) 790-4462 EA 1 3 14 2030 Confirm CD56 (123C3) Mouse (50 tests per kit) 790-4465 EA 1 1 11 2031 P63 (4A4) Mouse (50 tests per kit) 790-4509 EA 1 3 14 2032 EZ Prep (10x) (2 L bottle) 950-102 EA 2 5 17 2033 SSC (10X) (2 L bottle) 950-110 EA 1 3 14 2034 Cell Conditioning 1 (CC1) (2 L bottle) 950-124 EA 1 2 14 2035 Reaction Buffer (10X) (2 L bottle) 950-300 EA 7 12 28 Option Two (2) Estimated Total $ *VENDOR SHOULD USE EST. QTY WHEN PROVIDNG TOTAL PRICE CLIN 0003 Option Year Three (3) - October 1, 2014 through September 30, 2015 CLIN Name Stock Number Unit Min Qty Est Qty Max Qty Unit Price Total Price 3001 Label, Blank, Flap, 500 Roll 1358501 EA 1 5 10 3002 Liquid Coverslip (High Tempature) - 2 ltr Bottle 650-010 EA 7 23 42 3003 Endogenous Biotin Blocking Kit, CE (250 tests per kit) 760-050 EA 0 1 11 3004 Amplification Kit, CE (100 tests per kit) 760-080 EA 1 4 14 3005 iView DAB Detection Kit (250 tests per kit) 760-091 EA 1 3 14 3006 Negative Control Mouse IG (250 tests per kit) 760-2014 EA 1 2 11 3007 PROTEASE 1 (250 test per kit) 760-2018 EA 0 1 11 3008 HEMATOXYLIN (250 test per kit) 760-2021 EA 0 1 11 3009 BLUING REAGENT (250 tests per kit) 760-2037 EA 4 8 21 3010 CONFIRM ANTI-PSA (polyclonal) Primary Antigen (50 test per kit) 760-2506 EA 0 1 11 3011 Anti-CHROMOGRANIN A (LK2H10) PAB (50 test per kit) 760-2519 EA 1 3 14 3012 CONFIRM anti-CD20 (L26) PAB (50 tests per kit) 760-2531 EA 0 1 11 3013 Anti-Keratin, Pan (AE1/AE3 & PCK26) PAB (50 tests per kit) 760-2595 EA 1 2 11 3014 Cell Marque, Cytokeratin 5&6 (D5&16B4) (50 tests per kit) 790-4554 EA 1 2 11 3015 Cell Marque, CD45 (2B11 & PD7/26) (50 tests per kit) 760-4279 EA 0 1 11 3016 CDX-2 (CDX2-88) PAb, Cell Marque (50 tests per kit) 760-4380 EA 0 1 11 3017 Napsin A (Polyclonal) (50 test per kit) 760-4446 EA 0 1 11 3018 ultraView Universal Alkaline Phosphatase Red Detection (250 tests per kit) 760-501 EA 1 2 11 3019 Hematoxylin II (250 tests per kit) 790-2208 EA 3 7 15 3020 CONFIRM S100 (4C4.9) (50 tests per kit) 790-2914 EA 1 4 14 3021 CONFIRM Vimentin (V9) (50 tests per kit) 790-2917 EA 0 1 11 3022 CONFIRM CD34 (QBEnd/10) (50 tests per kit) 790-2927 EA 0 1 11 3023 CONFIRM MART-1/melan A (A103) (50 tests per kit) 790-2990 EA 1 4 14 3024 CONFIRM anti-CD3 (2GV6) (50 tests per kit) 790-4341 EA 1 2 11 3025 CONFIRMMelanosome (HMB45) Mouse (50 tests per kit) 790-4366 EA 1 2 11 3026 CONFIRM Thyroid Transcription Factor-1 (TTF-1) (8G7G3/1) (50 tests per kit) 790-4398 EA 1 3 14 3027 CONFIRM Synaptophysin (SP11) Rabbit (50 tests per kit) 790-4407 EA 1 2 11 3028 CONFIRM Cytokeratin 20 (SP33) Rabbit (50 tests per kit) 790-4431 EA 1 3 14 3029 CONFIRM Cytokeratin 7 (SP52) Rabbit (50 tests per kit) 790-4462 EA 1 3 14 3030 Confirm CD56 (123C3) Mouse (50 tests per kit) 790-4465 EA 1 1 11 3031 P63 (4A4) Mouse (50 tests per kit) 790-4509 EA 1 3 14 3032 EZ Prep (10x) (2 L bottle) 950-102 EA 2 5 17 3033 SSC (10X) (2 L bottle) 950-110 EA 1 3 14 3034 Cell Conditioning 1 (CC1) (2 L bottle) 950-124 EA 1 2 14 3035 Reaction Buffer (10X) (2 L bottle) 950-300 EA 7 12 28 Option Three (3) Estimated Total $ *VENDOR SHOULD USE EST. QTY WHEN PROVIDNG TOTAL PRICE CLIN 0004 Option Year Four (4) - October 1, 2015 through September 30, 2016 CLIN Name Stock Number Unit Min Qty Est Qty Max Qty Unit Price Total Price 4001 Label, Blank, Flap, 500 Roll 1358501 EA 1 5 10 4002 Liquid Coverslip (High Tempature) - 2 ltr Bottle 650-010 EA 7 23 42 4003 Endogenous Biotin Blocking Kit, CE (250 tests per kit) 760-050 EA 0 1 11 4004 Amplification Kit, CE (100 tests per kit) 760-080 EA 1 4 14 4005 iView DAB Detection Kit (250 tests per kit) 760-091 EA 1 3 14 4006 Negative Control Mouse IG (250 tests per kit) 760-2014 EA 1 2 11 4007 PROTEASE 1 (250 test per kit) 760-2018 EA 0 1 11 4008 HEMATOXYLIN (250 test per kit) 760-2021 EA 0 1 11 4009 BLUING REAGENT (250 tests per kit) 760-2037 EA 4 8 21 4010 CONFIRM ANTI-PSA (polyclonal) Primary Antigen (50 test per kit) 760-2506 EA 0 1 11 4011 Anti-CHROMOGRANIN A (LK2H10) PAB (50 test per kit) 760-2519 EA 1 3 14 4012 CONFIRM anti-CD20 (L26) PAB (50 tests per kit) 760-2531 EA 0 1 11 4013 Anti-Keratin, Pan (AE1/AE3 & PCK26) PAB (50 tests per kit) 760-2595 EA 1 2 11 4014 Cell Marque, Cytokeratin 5&6 (D5&16B4) (50 tests per kit) 790-4554 EA 1 2 11 4015 Cell Marque, CD45 (2B11 & PD7/26) (50 tests per kit) 760-4279 EA 0 1 11 4016 CDX-2 (CDX2-88) PAb, Cell Marque (50 tests per kit) 760-4380 EA 0 1 11 4017 Napsin A (Polyclonal) (50 test per kit) 760-4446 EA 0 1 11 4018 ultraView Universal Alkaline Phosphatase Red Detection (250 tests per kit) 760-501 EA 1 2 11 4019 Hematoxylin II (250 tests per kit) 790-2208 EA 3 7 15 4020 CONFIRM S100 (4C4.9) (50 tests per kit) 790-2914 EA 1 4 14 4021 CONFIRM Vimentin (V9) (50 tests per kit) 790-2917 EA 0 1 11 4022 CONFIRM CD34 (QBEnd/10) (50 tests per kit) 790-2927 EA 0 1 11 4023 CONFIRM MART-1/melan A (A103) (50 tests per kit) 790-2990 EA 1 4 14 4024 CONFIRM anti-CD3 (2GV6) (50 tests per kit) 790-4341 EA 1 2 11 4025 CONFIRMMelanosome (HMB45) Mouse (50 tests per kit) 790-4366 EA 1 2 11 4026 CONFIRM Thyroid Transcription Factor-1 (TTF-1) (8G7G3/1) (50 tests per kit) 790-4398 EA 1 3 14 4027 CONFIRM Synaptophysin (SP11) Rabbit (50 tests per kit) 790-4407 EA 1 2 11 4028 CONFIRM Cytokeratin 20 (SP33) Rabbit (50 tests per kit) 790-4431 EA 1 3 14 4029 CONFIRM Cytokeratin 7 (SP52) Rabbit (50 tests per kit) 790-4462 EA 1 3 14 4030 Confirm CD56 (123C3) Mouse (50 tests per kit) 790-4465 EA 1 1 11 4031 P63 (4A4) Mouse (50 tests per kit) 790-4509 EA 1 3 14 4032 EZ Prep (10x) (2 L bottle) 950-102 EA 2 5 17 4033 SSC (10X) (2 L bottle) 950-110 EA 1 3 14 4034 Cell Conditioning 1 (CC1) (2 L bottle) 950-124 EA 1 2 14 4035 Reaction Buffer (10X) (2 L bottle) 950-300 EA 7 12 28 Option Four (4) Estimated Total $ Estimated Aggregate Total $ *VENDOR SHOULD USE EST. QTY WHEN PROVIDNG TOTAL PRICE In accordance with FAR Part 11.104 Brand Name or Equal items applies to all items of this procurement. The Stock Numbers listed within the Schedule of Supplies are specific to Ventana Medical Systems, Inc. Vendors wishing to demonstrate the ability to provide an "equal" product shall furnish product literature with quote. Questions Submission: Interested Vendors must submit any questions concerning the solicitation by December 16, 2011 at 4:00 PM to ensure adequate time for Buyer's response. Questions must be submitted in writing, using email, to Kristin Tanner at contact@example.gov. Any other form will not be considered, phone calls or faxed questions will not be accepted or answered. Orders will be place by an authorized PVAHCS employee(s) by fax or phone. Orders placed by phone or fax will be followed up with a confirmation email. Person's authorized to place order: A list of individuals authorized to place order will be indentified at time of award of contract. Delivery: Supplies shall be shipped FOB Destination and be received within two (2) weeks of receipt of order to: Phoenix VA Health Care System Pathology and Laboratory Medicine Service Attn: Histology Section 650 E. Indian School Rd Phoenix, AZ 85012 Packaging and marking, items must be adequately packaged to prevent damage during shipping handling, and storage. Outer packages shall contain the complete contract number, obligation number, and shipping address. A packing list/slip shall be enclosed with shipment and shall include contract number, delivery order number, items and quantity ordered, and items and quantity shipped. The following FAR Provisions apply to this procurement: FAR 52.212-1, Instructions to Offerors -- Commercial Items (Jun, 2008) FAR 52.212-2, Evaluation - Commercial Items (Jan, 1999). Paragraph (a) Source Selection using Lowest Price Technically Acceptable (LPTA) (FAR 15.101-2) 1) This is a competitive Request for Quote (RFQ) that represents the best value to the Government conducted under FAR Part 15, Lowest Price Technically Acceptable (LPTA) source selection process. An Award will be made on the basis of the lowest price of quotes meeting or exceeding the acceptability standards for non-cost factors. 2) The Government will rank price quotes from lowest to highest, based on the total estimated cost (to include Options) of the quote. If the lowest priced quote receives an "Acceptable" Technical rating, then the evaluation process concludes and the Government will make preparations for contract award. If the lowest priced quote is not rated "Technically Acceptable", then the evaluation process continues until a technically acceptable quotes is determined. Technical Acceptability - to be technically acceptable, the quote must: I. Provide all of the required items listed above (in accordance with FAR 15.101-2(b)(1)): " If providing an "equal" product, comply with FAR Part 52.211-6 & VAAR 852.211-73, Brand Name or Equal. Technical capability and compatibility of the items offered to meet the Government's requirement. "Equal" product must meet all salient characteristics of the supplies to be considered technically acceptable. Product literature must be provided along with the quote to the following email contact@example.gov. " The completed pricing information filled in the Price/Cost Schedule (pages 2 through 11). " Any exceptions to the RFQ, including the SOW/Specifications, the delivery schedule and the terms and conditions. Unless specifically stated in the quote, the offeror agrees to everything in the RFQ/Delivery Order. II. Demonstrate that the offeror can provide all of the items requested in the SOW/Specifications section. This may include specifications, pictures, brochures, relevant past performance information, maintenance information, allowance for expansions or upgrades and other information that may be applicable. (b) Options. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s). (c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. FAR 52.212-3, Offeror Representations and Certifications - Commercial Items (April 2011) The offeror must submit a completed copy of the provision at with its quote. An offeror shall complete only paragraph (b) of this provision if the offeror has completed the annual representations and certifications electronically at http://orca.bpn.gov. If an offeror has not completed the annual representations and certifications electronically at the ORCA website, the offeror shall complete only paragraphs (c) through (o) of this provision. 52.216-1 TYPE OF CONTRACT (APR 1984) 52.211-6 BRAND NAME OR EQUAL (AUG 1999) 52.225-25 PROHIBITION ON ENGAGING IN SANCTIONED ACTIVITIES RELATING TO IRAN--CERTIFICATION (SEP 2010) 52.233-2 SERVICE OF PROTEST (SEP 2006) The following VAAR Provisions apply to the procurement: 852.211-72 TECHNICAL INDUSTRY STANDARDS (JAN 2008) 852.233-70 PROTEST CONTENT/ALTERNATIVE DISPUTE RESOLUTION (JAN 2008) 852.233-71 ALTERNATE PROTEST PROCEDURE (JAN 1998) 852.270-1 REPRESENTATIVES OF CONTRACTING OFFICERS (JAN 2008) The following FAR Clauses apply to this procurement: FAR 52.212-4, CONTRACT TERMS AND CONDITIONS - COMMERCIAL ITEMS (JUN, 2010) FAR 52.212-5, CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS - COMMERCIAL ITEMS (APR, 2011) APPLIES TO THIS ACQUISITION. THE FOLLOWING CLAUSES UNDER SUBPARAGRAPH (B) APPLY: 52.203-6 Restrictions on Subcontractor Sales to the Government (Sep 2006) 52.204-10 Reporting Executive Compensation and First-Tier Subcontract Awards (Jul 2010) 52.209-6 Protecting the Government's Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment (Dec 2010) 52.219-4 Notice of Price Evaluation Preference for HUBZone Small Business Concerns (JAN 2011) 52.219-8 Utilization of Small Business Concerns (JAN 2011) 52.219-28 Post Award Small Business Program Rerepresentation (APR 2009) 52.222-3 Convict Labor (June 2003) 52.222-19 Child Labor--Cooperation with Authorities and Remedies (JUL 2010) 52.222-21 Prohibition of Segregated Facilities (Feb 1999) 52.222-26 Equal Opportunity (Mar 2007) 52.222-35 Equal Opportunity for Veterans (SEP 2010) 52.222-36 Affirmative Action for Workers with Disabilities (Oct 2010) 52.222-37 Employment Reports on Veterans (SEP 2010) 52.222-40 Notification of Employee Rights Under the National Labor Relations Act (DEC 2010) 52.223-18 Encouraging Contractor Policies to Ban Text Messaging While Driving (AUG 2011) 52.225-1 Buy American Act--Supplies (FEB 2009) 52.232-34 Payment by Electronic Funds Transfer--Other than Central Contractor Registration (May 1999) 52.204-4 PRINTED OR COPIED DOUBLE-SIDED ON POSTCONSUMER FIBER CONTENT PAPER (MAY 2011) 52.216-18 ORDERING (OCT 1995) 52.216-19 ORDER LIMITATIONS (OCT 1995) (a) Minimum order. When the Government requires supplies or services covered by this contract in an amount of less than $50.00, the Government is not obligated to purchase, nor is the Contractor obligated to furnish, those supplies or services under the contract. (b) Maximum order. The Contractor is not obligated to honor-- (1) Any order for a single item in excess of 5 per day; (2) Any order for a combination of items in excess of 15 per day; or (3) A series of orders from the same ordering office within three (3) days that together call for quantities exceeding the limitation in paragraph (b)(1) or (2) of this section. (c) If this is a requirements contract (i.e., includes the Requirements clause at subsection 52.216-21 of the Federal Acquisition Regulation (FAR)), the Government is not required to order a part of any one requirement from the Contractor if that requirement exceeds the maximum-order limitations in paragraph (b) of this section. 52.216-22 INDEFINITE QUANTITY (OCT 1995) 52.217-8 OPTION TO EXTEND SERVICES (NOV 1999) 52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR 2000) 52.232-18 AVAILABILITY OF FUNDS (APR 1984) 52.232-19 AVAILABILITY OF FUNDS FOR THE NEXT FISCAL YEAR (APR 1984) The following VAAR clauses are also applicable to this acquisition: 852.203-70 COMMERCIAL ADVERTISING (JAN 2008) 852.211-73 BRAND NAME OR EQUAL (JAN 2008) 852.216-70 ESTIMATED QUANTITIES (APR 1984) 852.246-71 INSPECTION (JAN 2008) 852.273-76 ELECTRONIC INVOICE SUBMISSION (INTERIM - OCTOBER 2008) Vendors must submit all questions concerning this solicitation in writing to the Contract Specialist, Kristin Tanner by way of electronic mail (email) to contact@example.gov. Questions must be received no later than 4:00 PM Local Time (AZ Time), December 16, 2011. Quotes are required to be received in the contracting office no later than 12:00 PM Local Time on December 23, 2011. All quotes must be emailed to Contract Specialist, Kristin Tanner at contact@example.gov.